Document is current
Any future updates will be listed below
-
Authors
D’Andrea, Cristiano
Cazzaniga, Federico Angelo
Bistaffa, Edoardo
Barucci, Andrea
de Angelis, Marella
Banchelli, Martina
Farnesi, Edoardo
Polykretis, Panagis
Marzi, Chiara
Indaco, Antonio
Tiraboschi, Pietro
Giaccone, Giorgio
Matteini, Paolo
Moda, Fabio https://orcid.org/0000-0002-2820-9880
-
Funding
Funding for this research was provided by:
Italian Ministry of Health
EuroNanoMed3 ERANET cofund SPEEDY project
Tuscany Region (FAS-Salute 2018) project PRAMA
Italian Ministry of Health (GR-2021-12372019)
- License Information
-
More Information
Article History
Received: 21 March 2023
Accepted: 12 June 2023
First Online: 12 July 2023
Declarations
:
: Ethical approval is not required, based on national rules and legislation that does allow the use of residual material (leftover sample) taken for diagnostic purposes for anonymized research studies and in particular based on the recommendation CM/Rec(2016)6 of the Committee of Ministers of the Statue of the Council of Europe. All procedures were performed in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. CSF samples were collected for diagnostic purposes and the leftover samples were used for research experiments as detailed in the informed consent (CI22) signed by the patients prior to their inclusion.
: All authors read and approved the final manuscript.
: The authors declare that they have no competing interests.
